Niacin & Heart Disease: New Study Findings
Niacin’s Role: excess B Vitamin Linked to Heart Disease
Cleveland Clinic researchers have uncovered a new pathway connecting high levels of niacin,or vitamin B-3,to cardiovascular problems.Niacin was once widely recommended to lower cholesterol.
The research team, headed by dr. Stanley Hazen, identified 4PY, a byproduct of excess niacin, as a key factor in heart disease. clinical studies showed that elevated 4PY levels correlated strongly with increased risk of heart attack,stroke,and other cardiac issues. preclinical studies further revealed that 4PY directly causes vascular inflammation, damaging blood vessels and potentially leading to atherosclerosis.
The study, published in Nature Medicine, also highlights genetic links between 4PY and vascular inflammation, offering a basis for new treatments to reduce or prevent this inflammation. The research sheds light on the complex role of niacin in heart health.
According to Dr. Hazen, these findings reveal a previously unrecognized contributor to cardiovascular disease. He also noted the potential for diagnostic testing and the development of new treatments based on this pathway.
Niacin is prevalent in Western diets, with the U.S. and over 50 other countries mandating its addition to staple foods to prevent nutritional deficiencies, Hazen said. However, about 25% of patients studied had excessive 4PY levels, potentially contributing to cardiovascular disease.
Hazen likened niacin intake to filling a bucket with multiple taps. Once full, the overflow is processed into metabolites like 4PY.
Hazen advised against eliminating niacin entirely but suggested re-evaluating the continued fortification of foods with niacin in the U.S.
He also cautioned against the widespread use of over-the-counter niacin supplements for anti-aging purposes,urging patients to consult doctors and prioritize diets rich in fruits and vegetables while limiting carbohydrates.
These findings may clarify why niacin is no longer a primary treatment for lowering cholesterol. While it was initially used to lower LDL cholesterol, it proved less effective than other drugs and was linked to negative effects and higher mortality in past studies.
“Niacin’s effects have always been somewhat of a paradox,” Dr. Hazen said. “Despite niacin lowering of cholesterol, the clinical benefits have always been less than anticipated based on the degree of LDL reduction…We believe our findings help explain this paradox.”
The study authors emphasized the need for long-term research to understand the chronic effects of elevated 4PY levels on atherosclerosis.
This research is part of Dr. Hazen’s ongoing work on factors contributing to cardiovascular risk, including the link between gut microbes and heart disease.
What’s next
Future studies will focus on the long-term impact of 4PY on heart health and potential interventions to mitigate its effects. researchers will continue to explore the complex interplay between diet, metabolism, and cardiovascular disease.